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Abstract
The methylated arginines (MAs) monomethylarginine (MMA), asymmetric dimethylarginine
(ADMA), and symmetric dimethylarginine (SDMA) have been shown to be independent
predictors of cardiovascular disease. This article describes progress regarding the development of
an analytical method capable of rapidly analyzing MAs using capillary electrophoresis (CE) and
microchip electrophoresis (MCE) with laser-induced fluorescence (LIF) detection. Several
parameters including buffer composition and separation voltage were optimized to achieve an
ideal separation. The analytes of interest were derivatized with naphthalene-2,3-dicarboxaldehyde
(NDA) to produce fluorescent 1-cyanobenz[f]isoindole (CBI) derivatives and then subjected to CE
analysis. Baseline resolution of SDMA, ADMA, MMA, and arginine was achieved in less than 8
min. The limits of detection for SDMA, ADMA, MMA, and arginine were determined to be 15,
20, 25, and 5 nM, respectively, which are well below the expected plasma concentrations. The CE
separation method was then transferred to a glass MCE device with LIF detection. MAs were
baseline resolved in 3 min on-chip using a 14 cm separation channel with detection limits of
approximately 10 nM for each species. To the best of the authors’ knowledge, this is the first
report of the separation of MAs by MCE.
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Cardiovascular disease affects 80 million people in the United States and is the leading
cause of death in the nation.1 Although there are many factors that contribute to the onset of
cardiovascular disease, disruption of the endothelium is believed to play a central role. Nitric
oxide (NO) is a crucial molecule for maintaining proper endothelial function.2,3 Because it
is a small gaseous molecule, NO is capable of rapidly diffusing between cells and can cause
physiological responses distal to the site of production. These responses include
vasodilation, cellular signaling, and neurotransmission.2 It is thought that the reduced
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bioavailability of NO and its subsequent impact on the endothelium is responsible for the
development of cardiovascular diseases.2–4
The synthesis of NO is carried out by a family of enzymes called nitric oxide synthases
(NOSs). These enzymes catalyze the oxidation of arginine to produce citrulline and NO.5
Certain methylated arginines are competitive inhibitors of NOS and prevent NO from being
produced.6 Recent literature has shown that increased levels of these methylarginines (MAs)
have been found in patients suffering from pathologies such as stroke,7 various heart
diseases,8–15 and renal failure.16,17 The biochemical mechanisms behind the progression of
these diseases are not yet well understood, but all have been linked to disrupted endothelium
function. Given that MAs reduce the bioavailability of NO, it has been suggested that an
abundance of MAs may be responsible for disease onset and progression.
The compounds asymmetric NG,NG-dimethylarginine (ADMA) and NG-
monomethylarginine (MMA) mimic the NOS substrate arginine and competitively inhibit
NO from being synthesized, whereas symmetric NG,N′G-dimethylarginine (SDMA) does
not.18 All MAs, however, compete with arginine for cellular uptake by cationic amino acid
transporters and, therefore, all affect the cellular production of NO.19 Structures and average
plasma concentrations of arginine,10,11,15, 20–22 ADMA,7, 8, 10–13,15,20–22 MMA,8,20 and
SDMA7,8,10,11,15,21,22 are shown in Figure 1. Despite the fact that all methylated arginines
affect the synthesis of NO, most research in the literature has focused strictly on ADMA.
This is predominantly because ADMA is present at higher endogenous concentrations than
MMA and because SDMA does not competitively inhibit NOS. A recent study performed at
the Cleveland Clinic, however, demonstrated that the most robust independent predictor of
coronary artery disease was not the quantity of ADMA present but, rather, the arginine
methylation index (ArgMI), which is composed of the sum of the dimethylated species
concentrations divided by the concentration of the monomethylated form (Equation 1).8 This
index accurately predicted the extent of disease progression even without adjusting for
traditional risk factors. Because of the potential diagnostic proficiency of MAs, an analytical
method capable of analyzing them is necessary. This method must be rapid and relatively
inexpensive so that it could be used in future large-scale clinical trials.
Capillary electrophoresis (CE) is a useful analytical technique for the analysis of ionic
compounds such as MAs. CE provides relatively fast analyses compared with liquid
chromatography and is amenable to miniaturization. Microchip electrophoresis (MCE)
operates under the same separation principles as conventional CE but in a much smaller
platform. Microchips are only a fraction of the size, which allows them to use smaller
sample and reagent volumes and allows analyses to be performed even more rapidly. The
short analysis times afforded by an MCE device provide higher sample throughput than
other analytical techniques, which will be necessary for future clinical studies addressing
MAs. The present study employed laser-induced fluorescence (LIF) detection because of its
unparalleled sensitivity for CE and MCE analyses.23
There have been multiple reports in the literature describing the use of CE in the analysis of
MAs, but all have shortcomings. The analysis times of these other CE methods range from
13 to 18 min to resolve each of the MA species.24–27 Although this is not extremely long,
methods with shorter analysis times would be beneficial when analyzing a large number of
clinical samples. Also, despite their relatively long run times, several of the reported
methods still suffer from the comigration of the MA compounds. Additional limitations of
these other methods stem from their choices of detection techniques. The use of UV
detection25 is not ideal because of its lack of selectivity at 190 nm as well as its relatively
high detection limits (compared with LIF). The studies that used fluorescence detection in
the analysis of MAs chose to use derivatization reagents that hindered sample throughput
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either by necessitating that the labeling reaction take place overnight27 or by requiring the
sample to be heated for derivatization to occur.26 Neither of these approaches is ideal
because of the lengthy sample preparation times. In addition, the derivatization reagents
used in previous reports are fluorescent themselves. This complicates the separation by
requiring the excess derivatization reagent in the reaction mixture to be resolved from the
labeled analytes of interest. The CE method in the literature that is most promising uses a
tandem mass spectrometer as a detector. Despite having the best reported limits of detection
for MAs,24 the cost of analysis is quite large due to the high price of a CE-MS/MS system
and the need for expensive deuterated internal standards.
The purpose of this study was to develop a fast, relatively inexpensive analytical method for
the determination of methylarginines. MA standards were labeled with naphthalene-2,3-
dicarboxaldehyde (NDA), which is a fluorogenic derivatization reagent. Run conditions
were then optimized using CE with fluorescence detection to determine the conditions
necessary to achieve baseline resolution between the four analytes of interest. This
separation method was subsequently transferred to an MCE device, where the rapid analysis
of MAs was performed. To our best knowledge, this report is the first to demonstrate the




Standard solutions of arginine (Sigma Aldrich, St. Louis, MO), ADMA, SDMA, and MMA
(Enzo Life Sciences, Plymouth Meeting, PA) were prepared at 10 mM concentrations in 18
MΩ deionized water (Millipore, Billerica, MA). Samples were serially diluted to the desired
concentrations prior to CE analysis. A stock solution of 100 mM sodium tetraborate (Sigma
Aldrich) was made. Aliquots of the borate solution were adjusted to the indicated pH values
either by the addition of 1 N HCl or the addition of 1 N and/or 10 N NaOH. A 50 mM
aqueous solution of sulfobutylether-β-cyclodextrin (SBEC) (Cydex Pharmaceuticals,
Lenexa, KS) was also prepared. To formulate the run buffers, stock solutions of borate and
SBEC were combined and diluted to the appropriate concentrations. NDA (Invitrogen,
Carlsbad, CA) was dissolved in 1:1 acetonitrile:water to a final concentration of 5 mM. A 10
mM sodium cyanide (Sigma Aldrich) solution was prepared in water.
Derivatization
Because MAs are not natively fluorescent, the analytes were derivatized with NDA prior to
analysis. NDA labels primary amines in the presence of cyanide to produce fluorescent 1-
cyanobenz[f]isoindole (CBI) products. The excitation and emission maxima of CBI
derivatives are 440 nm and 490 nm, respectively. LIF detection was chosen for this study
because it provides the best detection limits for the determination of CBI derivatives.28,29
Samples were derivatized by combining equal volumes of methylarginine standards, 100
mM pH 9.25 sodium tetraborate, NDA, and sodium cyanide. The mixture was allowed to
react for 20 min under ambient conditions and then immediately injected into the CE. New
samples were prepared prior to every run. Three samples were analyzed under each set of
conditions.
Capillary Electrophoresis
A Beckman P/ACE MDQ CE instrument (Brea, CA) equipped with a 65 cm (50 cm to
window), 50 μm i.d./360 μm o.d. fused silica capillary (Polymicro Technologies, Phoenix,
AZ) was used in the development of a method to separate the MA species. Samples were
injected at 1.0 psi for 5 s. A Picometrics ZetaLIF external fluorescence detector
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(Ramonville, France) with a 445 nm CW diode laser (CrystaLaser, Reno, NV) was used to
detect the analytes. Both the CE parameters and the LIF detection were controlled by 32-
Karat software.
Microchip Electrophoresis
The procedure for the fabrication of the glass MCE device used in this article has been
previously reported by our lab.30,31 Briefly, photolithography was first performed on a
borofloat glass substrate coated with layers of chromium and positive photoresist (Telic,
Valencia, CA). A photomask (Infinite Graphics, Minneapolis, MN) containing the channel
design of interest was aligned over the glass and put into hard contact using a mask aligner
(ABM, Scotts Valley, CA). The glass plate was subsequently exposed to UV radiation from
the mask aligner and developed using 300 MIF Developer (AZ, Somerville, NJ). After
removing the exposed chromium with chromium etchant (Cyantek, Fremont, CA), the glass
was etched using a 20:14:66 solution of hydrofluoric acid (Acros Organic, Pittsburgh, PA),
nitric acid (Fisher Scientific, Pittsburgh, PA) and water, respectively, to create recessed
channels in the glass substrate. Etching continued until a channel depth of 15 μm was
reached as verified by a profilometer (Tencor, Milpitas, CA). Holes were then drilled in a
cover plate of glass to create reservoirs. The cover plate and channel plate were aligned and
subjected to a thermal bonding procedure using a programmable furnace (Fisher Scientific).
Following the thermal bond, the pieces of glass were fused together and could then be used
as an MCE device. The final channel dimensions were 15 × 45 μm with a 14 cm separation
channel (13 cm to detector). The sample reservoir side arm was 1 cm in length, whereas the
buffer and sample waste side arms were 4 cm long. The microchip channel design is
illustrated in Figure 2.
To operate the microchip device, all channels were first filled with run buffer. A few
microliters of derivatized sample were then loaded into the sample reservoir, and run buffer
was loaded into the buffer, buffer waste, and sample waste reservoirs (see Fig. 2). An
UltraVolt HV Rack high-voltage power supply (Ronkonkoma, NY) was used to apply 7 kV
to the sample reservoir and 11 kV to the buffer reservoir. The other two reservoirs were held
at ground. Applying the voltage in this fashion created a gated injection scheme that forced
fluid to flow continuously from the sample reservoir to the sample waste reservoir and from
the buffer reservoir to the buffer waste. Injections were made into the separation channel by
floating the high voltage in the buffer reservoir for 0.2 s. The high voltage was then
reapplied to reestablish gating and also to allow the components of the sample plug to
separate as they were electrokinetically driven down the separation channel. A custom
program to control the high-voltage application and data collection was written in house
using Labview software (National Instruments, Austin, TX).
To collect the fluorescence signal from the microchip device, a 445 nm PhoxX diode laser
(Market Tech, Scotts Valley, CA) was directed into an epifluorescence microscope (Nikon,
Melville, NY). The laser spot emanating from the microscope objective was focused onto
the MCE device just upstream from the buffer waste reservoir. As NDA-labeled analytes
passed across the laser spot, their fluorescent emission passed to a photomultiplier tube,
where the response was detected using the aforementioned Labview program.
Results and Discussion
Buffer Modification
Several reagents were evaluated as run buffer modifiers in an attempt to separate the MAs
(data not shown). Inadequate resolution was observed with free-zone electrophoresis using
either borate or a combination of borate and 3-(cyclohexylamino)-1-propanesulfonic acid
(CAPS) as a run buffer. Run buffer containing only borate led to complete comigration of
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the analytes of interest. The addition of CAPS into the borate enhanced the resolution and
allowed arginine, MMA, and either ADMA or SDMA to be separated; however, the two
dimethylarginines still comigrated. In an effort to improve resolution, β-cyclodextrin was
added in an attempt to resolve the two dimethyl species, but ultimately this did not improve
the separation. A micellar electrokinetic chromatography (MEKC) approach using sodium
dodecyl sulfate (SDS) was also evaluated, but this technique did not adequately resolve the
compounds.
Sulfobutylether-β-cyclodextrin was then evaluated based on a previous study that used it to
help resolve -phthaldehyde–labeled biogenic amines.32 It was discovered that SBEC
provided baseline resolution of our four analytes of interest. SBEC facilitated the separation
of NDA-labeled MAs by two mechanisms.33 First, the 1-cyanobenz[f]isoindole ring
partitioned into the hydrophobic core of the cyclodextrin. Because SBEC is anionic and has
a negative electrophoretic mobility, the net migration of the derivatized species was retarded
as the molecule interacted with the cyclodextrin ring. Neutral β-cyclodextrin did not affect
the separation because it lacked the negative mobility of SBEC, so there was no significant
retention during analyte partitioning. In addition to the interaction with the CBI ring, the
cationic guanidinium groups on the arginine residues interacted with the negatively charged
sulfate groups on the surface of the SBEC to form an ion pair. The methyl groups on MMA,
ADMA, and SDMA, however, attenuated the electrostatic attraction due to steric hindrance,
thereby diminishing the retention of the analyte. The extent of methylation and the
subsequent inhibition of electrostatic association with the cyclodextrin correctly predicts the
migration order of SDMA, ADMA, MMA, and arginine.
Separation Optimization
The concentrations of borate and SBEC as well as the run buffer pH and separation voltage
were systematically varied to determine the optimal conditions for the separation of 500 nM
MAs. The concentration of SBEC was varied from 0 to 20 mM in 5 mM increments to
evaluate its effect on the resolution between the analytes. A plot of average migration time
versus SBEC concentration is shown in Figure 3. This graph illustrates the increase in
resolution with increasing amounts of the anionic cyclodextrin. The MAs were completely
unresolved when no SBEC was included in the run buffer. (Data points from these
electropherograms were omitted from Fig. 3 for clarity.) It should be noted that complete
baseline resolution was achieved at all of the other SBEC concentrations. A run buffer
containing 5 mM SBEC was chosen for subsequent analyses because all analytes of interest
were resolved from one another in the shortest run times.
Sodium tetraborate is a common background electrolyte used in CE separations. It was
selected as the background electrolyte for this analysis because of its compatibility with the
NDA reaction mixture. The borate concentration in the run buffer was varied from 10 to 50
mM to determine the optimal conditions for separating the analytes of interest (Fig. 4).
Higher borate concentrations provided better resolution between adjacent peaks at the cost
of increased analysis times. Concentrations as low as 10 mM borate still resulted in baseline
resolution of the analytes. However, at low borate concentrations, the MAs had migration
times near the neutral marker. Although this was not problematic when analyzing MA
standards, for the analysis of more complex sample mixtures, additional peak capacity may
be needed to completely resolve the peaks of interest from other matrix components. As a
result, it was determined that 30 mM borate was optimal. At this concentration, complete
baseline resolution between the four MAs was obtained in reasonable run times of 8 min
while having supplementary peak capacity to prevent comigration of potentially interfering
species.
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The pH of the borate solution was also varied to ascertain the impact of pH on peak
resolution. Run buffers consisting of 30 mM borate and 5 mM SBEC were prepared at pH
9.00, 9.25, 9.50, 9.75, and 10.00. The effect of pH on migration time is shown in Figure 5. It
can be seen that the higher pH buffers produced longer migration times. All the compounds
were completely resolved regardless of run buffer pH. For simplicity, a pH of 9.25 was
selected for subsequent analyses as that is also the optimum pH at which to derivatize the
analytes of interest.
An investigation was also made into the effect of the applied separation voltages on
resolution and analysis time. As expected, higher voltages led to faster analyte migration and
shorter analysis times. This trend can be seen in Figure 6. As one of the goals of developing
this method was to increase throughput, the fastest possible separation is desired. Because
all species of interest remained baseline resolved at the higher field strengths, a separation
voltage of 28 kV (430 V/cm) was determined to be optimal.
The optimized separation parameters were determined after performing a systematic
evaluation of the effects of the analysis conditions, as described above. The final run buffer
was composed of 30 mM pH 9.25 borate and 5 mM SBEC. A separation voltage of 28 kV
was also determined to be ideal. Baseline resolution of all the analytes of interest was
achieved with run times of less than 8 min. A sample electropherogram illustrating the
optimized separation is shown in Figure 7. The limits of detection (LODs) for each of the
MA species were determined using this CE-LIF method. The experimentally determined
LODs (S/N = 3) for arginine, ADMA, MMA, and SDMA were 5, 20, 25, and 15 nM,
respectively, corresponding to mass detection limits of 10, 40, 50, and 30 amol. It should be
noted that all of the detection limits are below the concentrations expected in plasma. This
will allow endogenous levels of MAs to be detected and quantified using our method.
Microchip System
Once the conventional CE method had been optimized, similar separation parameters were
evaluated on an MCE device. Because the glass channels of the microchip are analogous in
composition to the walls of the silica capillary, the EOF for the two methods should be
similar, and a comparable separation should be achieved. The MCE device was operated
using the same 30 mM borate/5 mM SBEC run buffer. To perform a gated injection on a
microchip, however, two high-voltage electrodes were required to produce the two different
flow streams as opposed to the linear electric field necessary for a conventional CE
separation. It was determined that applied voltages of 7 kV and 11 kV were optimal for the
sample and buffer reservoirs on the microchip, respectively. Once this optimization was
completed, a sample containing 1 μM of each NDA-derivatized MA species was loaded into
the sample reservoir and analyzed on-chip. An electropherogram depicting that separation is
shown in Figure 8. Near-complete baseline resolution was achieved for the MAs on an MCE
device in approximately 3 min. The on-chip detection limits (S/N = 3) for all four analytes
of interest were determined to be approximately 10 nM. We believe that this is the first
report describing the separation of methylarginines on an MCE device. The use of MCE will
greatly facilitate the throughput of the analytical method because of the shorter analysis
times without sacrificing sensitivity, as evidenced by the low LODs.
Improvements could be made to decrease analysis times by increasing the field strengths in
the microchip. In this study, the separation current in the channels was limited to a 100 μA
maximum. This limit was set as an arbitrary threshold to prevent Joule heating from
producing bubbles in the chip. As a result, gating voltages of 7 kV and 11 kV were chosen
because they provided the highest field strengths while preventing the current from
exceeding the maximum threshold. The 7/11 kV voltage scheme corresponded to field
strengths of 560 V/cm. However, field strengths well over 1000 V/cm are theoretically
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possible before boiling the buffer.34 Because no significant bubble formation occurred under
our conditions and because higher electric fields have been reported, higher voltages could
be applied to our chip to help increase the rate of analysis and improve separation efficiency.
Conclusions
A CE-based separation method was developed for the determination of four methylarginine
species involved in cardiovascular disease. A run buffer containing 30 mM pH 9.25 borate
and 5 mM SBEC and a separation voltage of 28 kV (430 V/cm) were determined to be
optimal run parameters. Baseline resolution was achieved between NDA-derivatized
SDMA, ADMA, MMA, and arginine in less than 8 min. The separation method was then
transferred to an MCE device where the analytes of interest were able to be separated in 3
min over a 13 cm separation distance. This is the first report demonstrating the separation of
MAs using MCE.
Future work will be conducted to improve the separation of the MAs on-chip by modifying
the applied voltages and the run buffer composition. Once sufficient separations are
reproducibly achieved, additional separation channels will be incorporated into the device.
This will allow several samples to be analyzed simultaneously while maintaining the fast
analysis times. Studies are currently underway to develop a solid phase extraction sample
preparation procedure to selectively isolate MAs from plasma. When this method is
optimized, clinical samples obtained from patients with and without coronary atherosclerosis
will be analyzed by MCE. This high-throughput method will allow a large number of
samples to be analyzed so that more data can be generated and used to determine the
correlation between MAs and the extent of atherosclerosis. This information will help to
improve the understanding of the pathways involved in the onset and progression of CVD.
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Structures and average plasma concentrations of the methylarginines.7,8,10–13,15,20–22
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Schematic of the microchip electrophoresis device. Channel dimensions were 15 × 45 μm,
and the separation distance was 14 cm (13 cm to detector). The sample reservoir side arm
was 1 cm in length, whereas the buffer and sample waste side arms were 4 cm long.
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The effect of sulfobutylether-β-cyclodextrin concentration on analyte migration times. The
run buffer composition was 30 mM pH 9.25 borate, and the separation voltage was 23 kV.
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The effect of sodium borate concentration (pH 9.25) on analyte migration times. The run
buffer composition was 5 mM sulfobutylether-β-cyclodextrin, and the separation voltage
was 28 kV.
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The effect of run buffer pH on analyte migration times. The run buffer composition was 30
mM borate and 5 mM sulfobutylether-β-cyclodextrin, and the separation voltage was 28 kV.
Linz et al. Page 14














The effect of applied separation voltage on analyte migration times. The run buffer
contained 30 mM pH 9.25 borate and 5 mM sulfobutylether-β-cyclodextrin.
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Electropherogram depicting the optimized separation of the MAs with conventional
capillary electrophoresis. A field strength of 430 V/cm was applied across a 65 cm capillary
(50 cm to window). The run buffer contained 30 mM pH 9.25 sodium tetraborate and 5 mM
sulfobutylether-β-cyclodextrin.
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Electropherogram depicting the separation of methylated arginines on a microchip
electrophoresis device. Channel dimensions were 15 × 45 μm with a separation distance of
14 cm (13 cm to detector). The run buffer contained 30 mM pH 9.25 sodium tetraborate and
5 mM sulfobutylether-β-cyclodextrin.
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Figure 9. Equation 1
Arginine methylation index.
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